Burosumab and Dental Abscesses in Children With X‐Linked Hypophosphatemia

Burosumab and Dental Abscesses in Children With X‐Linked Hypophosphatemia

ABSTRACT X‐linked hypophosphatemia (XLH) is a rare genetic disorder that disrupts skeletal and dental mineralization. In addition to rickets in children, XLH patients also have frequent spontaneous dental abscesses that increase the risk of tooth loss and may lead to facial cellulitis. Hypomineraliz...

Full description

Bibliographic Details
Main Authors:	Margaux Gadion, Agathe Hervé, Julia Herrou, Anya Rothenbuhler, Violaine Smail‐Faugeron, Frédéric Courson, Agnès Linglart, Catherine Chaussain, Martin Biosse Duplan
Format:	Article
Language:	English
Published:	Oxford University Press 2022-11-01
Series:	JBMR Plus
Subjects:	DENTAL BIOLOGY \|MATRIX MINERALIZATION BONE MATRIX DISORDERS OF CALCIUM/PHOSPHATE METABOLISM PTH/VIT D/FGF23 CELL/TISSUE SIGNALING – ENDOCRINE PATHWAYS
Online Access:	https://doi.org/10.1002/jbm4.10672

Similar Items

Sex‐Specific Differences in Gsα‐Mediated Signaling Downstream of PTH1R Activation by Abaloparatide in Bone
by: Srilatha Swami, et al.
Published: (2022-12-01)

Vitamin D and Breast Cancer: Mechanistic Update
by: JoEllen Welsh
Published: (2021-12-01)

Vitamin D Actions: The Lung Is a Major Target for Vitamin D, FGF23, and Klotho
by: Ghislaine Gayan‐Ramirez, et al.
Published: (2021-12-01)

Probing the Scope and Mechanisms of Calcitriol Actions Using Genetically Modified Mouse Models
by: Dengshun Miao, et al.
Published: (2021-01-01)

Positive Response to One-Year Treatment With Burosumab in Pediatric Patients With X-Linked Hypophosphatemia
by: Silvia Martín Ramos, et al.
Published: (2020-02-01)

Growth pattern in children with X-linked hypophosphatemia treated with burosumab and growth hormone
by: Diana-Alexandra Ertl, et al.
Published: (2022-11-01)

Acute High Dietary Phosphorus Following Low‐Phosphorus Diet Acclimation Does Not Enhance Intestinal Fractional Phosphorus Absorption in Nephrectomized Male Rats
by: Kendal M Burstad, et al.
Published: (2022-12-01)

Reduction of Calciprotein Particles in Adults Receiving Infliximab for Chronic Inflammatory Disease
by: Mark K Tiong, et al.
Published: (2021-06-01)

Vitamin D: Bolus Is Bogus—A Narrative Review
by: Richard B. Mazess, et al.
Published: (2021-12-01)

Man of Steel Syndrome: Silicone and Mineral Oil Injections With Associated Hypercalcemia, Hypophosphatemia, and Proximal Muscle Weakness
by: Arash Shirvani, et al.
Published: (2019-10-01)

Cardiovascular health in pediatric patients with X-linked hypophosphatemia under two years of burosumab therapy
by: Avivit Brener, et al.
Published: (2024-05-01)

Real‐world data of Brazilian adults with X‐linked hypophosphatemia (XLH) treated with burosumab and comparison with other worldwide cohorts
by: Maria Helena Vaisbich, et al.
Published: (2024-02-01)

Development and Validation of Novel Free Vitamin D Equations: The Health Aging and Body Composition Study
by: Jonathan H. Cheng, et al.
Published: (2023-09-01)

Hypervitaminosis D Secondary to a CYP24A1 Loss‐of‐Function Mutation: An Unusual Cause of Hypercalcemia in Two Siblings
by: Lucy Collins, et al.
Published: (2023-09-01)

Comparable Initial Engagement of Intracellular Signaling Pathways by Parathyroid Hormone Receptor Ligands Teriparatide, Abaloparatide, and Long‐Acting PTH
by: Tadatoshi Sato, et al.
Published: (2021-05-01)

Tumor-induced osteomalacia: A systematic literature review
by: Noelia Álvarez-Rivas, et al.
Published: (2024-06-01)

Integrated View on the Role of Vitamin D Actions on Bone and Growth Plate Homeostasis
by: Lieve Verlinden, et al.
Published: (2021-12-01)

Osteitis Fibrosa Cystica
by: Waldemar Misiorowski, et al.
Published: (2020-09-01)

A Distinct Variant of Pseudohypoparathyroidism (PHP) First Characterized Some 41 Years Ago Is Caused by the 3‐kb STX16 Deletion
by: Zentaro Kiuchi, et al.
Published: (2021-07-01)

Burosumab for the treatment of cutaneous-skeletal hypophosphatemia syndrome
by: Lillian Abebe, et al.
Published: (2024-03-01)

A Normal FGF23 Does Not Preclude Tumor‐Induced Osteomalacia
by: Neeharika Nandam, et al.
Published: (2021-02-01)

Anticipated effects of burosumab treatment on long-term clinical sequelae in XLH: expert perspectives
by: Lothar Seefried, et al.
Published: (2023-07-01)

The Role of Daily Dialysate Calcium Exposure in Phosphaturic Hormones in Dialysis Patients
by: Francesca K. Martino, et al.
Published: (2024-07-01)

Dental impact of anti-fibroblast growth factor 23 therapy in X-linked hypophosphatemia
by: Elis J. Lira dos Santos, et al.
Published: (2023-12-01)

Burosumab for X-linked hypophosphatemia in children and adolescents: Opinion based on early experience in seven European countries
by: M. Zulf Mughal, et al.
Published: (2023-01-01)

Growth hormone treatment improves final height in children with X-linked hypophosphatemia
by: Julia André, et al.
Published: (2022-12-01)

Complications and Treatments in Adult X-Linked Hypophosphatemia
by: Yasuo Imanishi, et al.
Published: (2022-09-01)

Biomarkers of Vitamin D Metabolism and Hip and Vertebral Fracture Risk: The Multi‐Ethnic Study of Atherosclerosis
by: Simon Hsu, et al.
Published: (2022-12-01)

Interactions between FGF23 and vitamin D
by: Mohammed S Razzaque
Published: (2022-09-01)

FGF23, Hypophosphatemia, and Emerging Treatments
by: Erik A Imel, et al.
Published: (2019-08-01)

Impact of burosumab on lower limb alignment in children with X-linked hypophosphatemia
by: David B. Frumberg, MD, FAAOS, et al.
Published: (2024-02-01)

Nephrocalcinosis tendency does not worsen under burosumab treatment for X-linked hypophosphatemic rickets: a multicenter pediatric study
by: Shelly Levi, et al.
Published: (2024-12-01)

Optimization of PTH/PTHrP Hybrid Peptides to Derive a Long‐Acting PTH Analog (LA‐PTH)
by: Hiroshi Noda, et al.
Published: (2020-07-01)

Burosumab - new potent treatment for X-linked hypophosphatemia and tumor-induced osteomalacia
by: Magda Wojtuś, et al.
Published: (2023-07-01)

Comparative Analysis of Vascular Calcification Risk Factors in Pre-Hemodialysis and Prevalent Hemodialysis Adult Patients: Insights into Calcification Biomarker Associations and Implications for Intervention Strategies in Chronic Kidney Disease
by: Marko Petrović, et al.
Published: (2024-04-01)

PTH, FGF-23, Klotho and Vitamin D as regulators of calcium and phosphorus: Genetics, epigenetics and beyond
by: Ignacio Portales-Castillo, et al.
Published: (2022-09-01)

Galectins use N-glycans of FGFs to capture growth factors at the cell surface and fine-tune their signaling
by: Aleksandra Gedaj, et al.
Published: (2023-05-01)

Case Report: Unexplained Mild Hypophosphatemia and Very High Serum FGF23 Concentrations
by: Ariadne Bosman, et al.
Published: (2023-10-01)

Vitamin D Receptor Mediates a Myriad of Biological Actions Dependent on Its 1,25‐Dihydroxyvitamin D Ligand: Distinct Regulatory Themes Revealed by Induction of Klotho and Fibroblast Growth Factor‐23
by: Mark R Haussler, et al.
Published: (2021-01-01)

Shedding Light on the Complex Regulation of FGF23
by: Marc G. Vervloet
Published: (2022-04-01)